Abstract

A research on acute toxicity of effervescent tablet from Piper betle leaf extractum on wistar albino female rats was done. This research aimed to determine acute toxicity potential of effervescent tablet from piper betle leaf extractum, evaluated clinical symptom that perhaps occur due to the giving of effervescent tablet, single dosage orally on 24 hours to 15 days observation. The research uses female rats, which are divided into 5 groups. Group I was negative control with aquadest. Group II was given sample with 0,38 g/kgBW dosage. Then, succesively group III with 1,03 g/kgBW dosage, group IV with 2,79 g/kgBW dosage and group V was given test sample with highest dosage, that was 7,50 g/kgBW dosage. On the basis of data analysis result having been performed both quantitively and qualitatively, it could be said that in general, the giving of effervescent tablet from Piper betle leaf extractum single dosage orally on female rats from 0,38 g/kgBW dosage to highest level (7,50 g/kgBW) or approximately 19,74 times of therapy dosage, didn't cause toxic effect which causing damage on lung, liver, kidney, heart, spleen, stomach and intestine. It didn't cause mortality on research animal. So we can determine the quasi LD^, that was bigger than 7,50 g/kgBW, according to Loomis criteria (1978), that acute toxicity potential of effervescent tablet from piper betle extractum was practically not toxic category. Thus based on ANOVA result with 95 % significance level, it could be said that the giving of effervescent tablet from piper betle leaf extractum didn't show significant differences to average body weight changes and organ weight.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.